Reversible cerebral vasoconstriction syndrome: a medical challenge in the peripartum period requiring a multimodal approach: a case report Authors: Edith Elianna Rodríguez, María Monica Ortiz, Monica Mora, Christian Rubio, Gabriela Franco, Paola A Castellanos, Víctor S Rangel Published: 2026 ABSTRACT AbstractReversible cerebral vasoconstriction syndrome is a rare but potentially life-threatening neurological disorder that may occur during pregnancy and the postpartum period and represents an important diagnostic challenge because of its overlap with other obstetric neurological emergencies. We report the case of a 35-year-old woman with a dichorionic diamniotic twin pregnancy who developed severe preeclampsia requiring cesarean delivery at 30 weeks of gestation. On the fifth postpartum day, she experienced thunderclap headache, generalized seizures, and refractory cerebral vasospasm complicated by subarachnoid hemorrhage, cerebral ischemia, and intracranial hypertension. She was managed in a specialized maternal neurocritical care unit using a multimodal strategy that included continuous neuromonitoring with transcranial Doppler ultrasonography, cerebral oxygenation and metabolic monitoring, electroencephalography, intracranial pressure monitoring, serial cerebral angiography with selective intra-arterial milrinone infusion, and, ultimately, ultrasound-guided stellate ganglion block as rescue therapy. Progressive neurological recovery followed, allowing liberation from mechanical ventilation, initiation of rehabilitation, and hospital discharge with a favorable functional outcome. This case highlights the importance of considering reversible cerebral vasoconstriction syndrome in postpartum women presenting with acute neurological deterioration. Early diagnosis, multidisciplinary management, and multimodal neuromonitoring may facilitate individualized treatment and timely therapeutic escalation in patients with refractory cerebral vasospasm. Further prospective studies are needed to better define the role of advanced neuromonitoring and rescue therapies in this rare condition.Key words: postpartum period, pregnancy complications, reversible cerebral vasoconstriction syndrome AJOG Global Reports at a Glance Why was this study conducted? To describe the diagnosis and multimodal management of refractory reversible cerebral vasoconstriction syndrome during the peripartum period, a rare neurological emergency with limited evidence to guide treatment. Key findings A postpartum woman with refractory cerebral vasospasm achieved a favorable neurological recovery following individualized management guided by multimodal neuromonitoring, including endovascular intra-arterial milrinone infusion and ultrasound-guided stellate ganglion block as rescue therapy. What does this add to what is known? This report highlights the potential role of multimodal neuromonitoring in guiding treatment escalation and proposes a practical framework for managing refractory reversible cerebral vasoconstriction syndrome during pregnancy and the puerperium. Introduction Pregnancy and the postpartum period pose unique diagnostic challenges in women presenting with acute neurological symptoms. The differential diagnosis includes several potentially life-threatening conditions, particularly posterior reversible encephalopathy syndrome (PRES), preeclampsia, eclampsia, and cerebral venous sinus thrombosis. Physiological and hormonal changes associated with pregnancy and the puerperium, including endothelial dysfunction, altered cerebral autoregulation, hemodynamic adaptations, and changes in vascular tone, may contribute to overlapping clinical manifestations and complicate the diagnostic evaluation.1,2 Reversible cerebral vasoconstriction syndrome (RCVS) is a rare but potentially life-threatening clinico-radiological syndrome characterized by recurrent thunderclap headaches and reversible multifocal segmental narrowing of the cerebral arteries.3 Headache is the hallmark manifestation, with a hyperacute onset, and is commonly described as an “explosive headache” or “the worst headache of life.”4,5 Neurovascular imaging typically demonstrates a characteristic “string-of-beads” appearance resulting from alternating segments of arterial constriction and dilatation, with spontaneous resolution generally occurring within 12 weeks.3,5,6 Although the true incidence of RCVS remains unknown, it is estimated to account for approximately 0.26% of headache-related consultations and predominantly affects women between 20 and 50 years of age.6,7 Pregnancy and puerperium are recognized precipitating factors, accounting for approximately 9% to 13% of cases.5,8 Despite its generally favorable prognosis, RCVS may be complicated by ischemic stroke, intracranial hemorrhage, vasogenic edema, and, in severe cases, death, with mortality rates reaching up to 9.1%.9 Early recognition and prompt perfusion-directed management are therefore essential to minimize neurological injury and optimize clinical outcomes.7 Evidence on RCVS during pregnancy and the puerperium remains scarce, particularly in Latin America. We present the case of a 35-year-old postpartum woman with RCVS complicated by refractory severe cerebral vasospasm who was successfully managed in a maternal neurocritical intensive care unit (ICU) using a multimodal approach guided by advanced neuromonitoring at a tertiary referral hospital in Bogotá, Colombia. The study was conducted in accordance with the principles of the Declaration of Helsinki. Written informed consent was obtained from the patient. Ethical approval was granted (Human Research Ethics Committee of Hospital Universitario Mayor–Méderi Approval No. CEISH-2026023). The report follows the CARE guidelines for case reports. Case presentation The patient was a 35-year-old woman with a dichorionic diamniotic twin pregnancy and a 5-year history of migraine-like headaches, which worsened during pregnancy and had been managed with analgesics and unknown homeopathic treatment. At 30 weeks of gestation, she was diagnosed with nonsevere preeclampsia. She subsequently underwent cesarean delivery because of progression to severe preeclampsia with hepatic and renal involvement, evidenced by elevated liver enzymes (alanine aminotransferase, 72.5 U/L; aspartate aminotransferase, 62.68 U/L) and oliguria (<0.5 mL/kg/h). After delivery, she was admitted to the obstetric and neurocritical ICU. Magnesium sulfate was administered according to the institutional protocol. Following delivery, the patient developed severe refractory hypertension requiring continuous intravenous infusions of nitroglycerin, sodium nitroprusside, and labetalol at maximal doses, in addition to five oral antihypertensive agents. On the fifth postpartum day, she experienced an abrupt neurological deterioration characterized by the sudden onset of a thunderclap headache, described as “the worst headache of my life,” in the setting of severe hypertension (200/110–215/108 mmHg), followed by generalized tonic–clonic seizures. She was diagnosed with eclampsia complicated by refractory status epilepticus, requiring endotracheal intubation, mechanical ventilation, and a barbiturate-induced coma guided by bispectral index monitoring. Cerebral vasospasm and subarachnoid hemorrhage were identified at the onset of neurological deterioration. Endovascular treatment with selective intra-arterial milrinone infusion was performed, and the subsequent clinical course is summarized in Figure 1. Standard therapeutic strategies were initiated, including calcium channel blockers, cilostazol, magnesium sulfate, lidocaine infusion, and optimization of cerebral autoregulation and cerebral perfusion pressure. Severe cerebral vasospasm was serially monitored using transcranial Doppler ultrasonography. The intensity of treatment was guided by a multimodal neuromonitoring strategy that extended beyond bedside ultrasonography and included cerebral oxygenation and metabolic monitoring through a jugular bulb venous catheter, serial video electroencephalography, and intracranial pressure monitoring with an external ventricular drain. The patient underwent six serial cerebral angiographies with selective intra-arterial milrinone infusion. Despite these interventions, she developed refractory cerebral vasospasm, progressive cerebral edema, and persistent cerebral anaerobic metabolism, requiring placement of an external ventricular drain for the treatment and monitoring of intracranial hypertension. These clinical and angiographic findings were consistent with RCVS. Following hemodynamic profile demonstrates fluctuating systemic pressures with intermittent elevations in intracranial pressure, suggesting periods of reduced cerebral perfusion pressure. Transcranial Doppler reveals dynamic changes in middle cerebral artery mean velocities, with transient elevations and increased Lindegaard ratios, consistent with episodes of cerebral vasospasm or increased cerebrovascular resistance. Metabolic parameters show marked alterations, particularly a profound drop in OGI, indicating impaired cerebral oxygen utilization and possible mitochondrial dysfunction or ischemic stress. Red arrows and lines show serial angiographies with intra-arterial milrinone infusion, Blue arrows show the external ventricular drainage position and the purple arrow shows the stellate ganglion blockage ICP, intracranial pressure; MAP, mean arterial pressure; SAP, systolic arterial pressure; MCA, middle cerebral artery; OGI, oxygen–glucose index; LOI, lactate–oxygen index; LGI, lactate–glucose index. Rodríguez. Reversible cerebral vasoconstriction syndrome: a medical challenge in the peripartum period requiring a multimodal approach. Am J Obstet Gynecol 2026. Because cerebral vasospasm remained refractory, an ultrasound-guided stellate ganglion block using a trans-thyroid approach was performed on the tenth day after neurological deterioration. Follow-up cerebral angiography demonstrated marked improvement in the severity of vasospasm, accompanied by progressive neurological recovery. The doses of all medications are provided in the Table. Although initial hepato-renal dysfunction was identified on admission, there was no further evidence of organ dysfunction after the first day of intensive care unit admission. The patient was subsequently weaned from mechanical ventilation and initiated an intensive rehabilitation program. Final brain computed tomography revealed only a small ischemic lesion in the anterior cerebral artery territory. She was discharged on hospital day 42 with a Glasgow Outcome Scale–Extended score of 6. TablePharmacological treatments for cerebral vasospasm, including dosages and routes of administration used during the patient's clinical management.Table dummy alt textDrugRouteAverage doseMaximal doseTotal drug use daysOral administrationNimodipineO20 mg / 4 h20 mg / 4 h27CilostazolO100 mg / 12 h100 mg / 12 h27NifedipineO60 mg / 12 h60 mg / 12 h42ValsartanO80 mg / 12 h160 mg / 12 h42PrazosinO2 mg / 8 h4 mg / 6 h27MinoxidilO5 mg / 12 h10 mg / 12 h15HydrochlorothiazideO25 mg / 24 h25 mg / 12 h24Intravenous administrationMagnesium sulfateIV4000 mg loading dose + 1000 mg/h for 24 hours4000 mg loading dose + 1000 mg/h for 24 hours4 schemesLabetalolIV0.5–2 mg/min5 mg/min8NitroglycerinIV0.1–0.2 mcg/kg/min3 mcg/kg/min12Sodium nitroprussideIV0.1–0.2 mcg/kg/min3 mcg/kg/min9MilrinoneIV0.375–0.75 mcg/kg/min0.75 mcg/kg/min15Intra-arterial administrationMilrinoneIA4–15 mg20 mg6 schemesPeripheral nerve injectionBupivacainePNI20–40 mg30 mg1O, oral; IV, intravenous; IA, intra-arterial; PNI, peripheral nerve injection.Rodríguez. Reversible cerebral vasoconstriction syndrome: a medical challenge in the peripartum period requiring a multimodal approach. Am J Obstet Gynecol 2026. Pharmacological treatments for cerebral vasospasm, including dosages and routes of administration used during the patient's clinical management. O, oral; IV, intravenous; IA, intra-arterial; PNI, peripheral nerve injection. Rodríguez. Reversible cerebral vasoconstriction syndrome: a medical challenge in the peripartum period requiring a multimodal approach. Am J Obstet Gynecol 2026. Patient perspective: “Facing this rare and frightening illness, in the midst of becoming a mother, was the hardest experience of my life. The pain, fear, and uncertainty were overwhelming. Yet I am profoundly grateful for the interdisciplinary team and the maternal–neurocritical intensive care unit that monitored and cared for me with such expertise, dedication, and humanity. Their work gave me back my health and my family.” Discussion Postpartum neurological emergencies represent a major diagnostic challenge for both obstetricians and intensivists. Acute neurological deterioration, including seizures, thunderclap headache, or focal neurological deficits, is frequently attributed to obstetric conditions such as eclampsia or PRES, a neurotoxic disorder characterized by subcortical vasogenic edema and neurological dysfunction.10 Similarly, HELLP syndrome, considered a severe manifestation of preeclampsia, may be complicated by catastrophic neurological events, particularly intracranial hemorrhage.11 Cerebral venous sinus thrombosis should also be considered in the differential diagnosis, especially in low- and middle-income countries where pregnancy-related cases are more frequently reported, with estimated incidences of 400 to 500 per 100,000 deliveries.12 RCVS, in contrast, is very rare, typically arising 1 to 6 weeks after an uncomplicated pregnancy from multifocal arterial vasoconstriction and dilation within the spectrum of postpartum angiopathy, where vascular dysregulation involves placental growth factor, soluble fms-like tyrosine kinase-1, and transforming growth factor-β.5,13 RCVS has also been associated with several precipitating factors, including immunosuppressive therapy, vasoactive substances (eg, phenylpropanolamine, selective serotonin reuptake inhibitors, and cocaine), catecholamine-secreting tumors, cervical artery dissection, and other less common triggers.7 Current management focuses on relieving cerebral vasoconstriction, optimizing cerebral perfusion, and preventing secondary neurological injury. Calcium channel blockers remain the mainstay of medical treatment, with nimodipine and verapamil demonstrating benefits in headache control and recovery of cerebral vasospasm assessed by transcranial Doppler.14,15 Hemodynamic optimization is commonly used to preserve cerebral perfusion despite arterial narrowing, although excessive augmentation may increase blood–brain barrier permeability and potentially worsen cerebral edema.16,17 In patients with refractory vasospasm, endovascular therapy using intra-arterial vasodilators such as milrinone, nimodipine, or nicardipine has emerged as a reasonable rescue strategy, although current evidence is limited to small case series.18 Even less evidence supports other rescue interventions, including intrathecal vasodilators, stellate ganglion block, and decompressive craniectomy, whose use remains restricted to anecdotal reports despite their biological rationale in selected refractory cases.4,7 Our patient developed refractory cerebral vasospasm complicated by cerebral ischemia and intracranial hypertension, which were detected through multimodal neuromonitoring. Continuous bedside monitoring enabled timely escalation and de-escalation of therapy, ultimately leading to the use of stellate ganglion block as a rescue intervention. The favorable neurological outcome observed in this case suggests that multimodal neuromonitoring, combined with individualized stepwise management, may facilitate early recognition of disease progression and guide therapeutic decision-making in patients with severe refractory RCVS. Based on the available evidence and the clinical experience derived from this case, we propose a framework of multimodal treatment strategies for the management of refractory cerebral vasospasm associated with RCVS during pregnancy and the puerperium (Figure 2). However, given the rarity of this condition and the limited evidence supporting many of the advanced therapeutic interventions, this framework should be interpreted with caution and should not be considered a validated management guideline. Further studies are needed to define the role, timing, and clinical impact of multimodal neuromonitoring and rescue therapies in patients with refractory disease. Proposed treatment strategies for cerebral vasospasm associated with reversible cerebral vasoconstriction syndrome during pregnancy and the puerperium. Management includes immediate stabilization, systemic vasodilator therapy, hemodynamic optimization, endovascular therapy with intra-arterial vasodilators, external ventricular drainage for intracranial hypertension when indicated, stellate ganglion block as rescue therapy, and decompressive craniectomy in selected refractory cases ICH, Intracranial hypertension; ICP, intracranial pressure. Rodríguez. Reversible cerebral vasoconstriction syndrome: a medical challenge in the peripartum period requiring a multimodal approach. Am J Obstet Gynecol 2026. Conclusion RCVS should be considered in the differential diagnosis of pregnant and postpartum women presenting with acute neurological deterioration, particularly when severe headache, seizures, or refractory cerebral vasospasm coexist with hypertensive disorders of pregnancy. This case illustrates that early diagnosis, multidisciplinary management, and multimodal neuromonitoring may facilitate timely therapeutic escalation and individualized treatment in patients with severe refractory disease. Although advanced rescue therapies may represent promising treatment options in selected cases, their role remains to be established. CRediT authorship contribution statement Edith Elianna Rodríguez: Writing – review & editing, Writing – original draft, Visualization, Validation, Supervision, Project administration, Methodology, Investigation, Conceptualization. María Monica Ortiz: Writing – review & editing, Writing – original draft, Visualization, Validation, Supervision, Investigation, Conceptualization. Monica Mora: Writing – review & editing, Writing – original draft, Visualization, Validation, Resources, Methodology, Investigation. Christian Rubio: Writing – review & editing, Writing – original draft, Visualization, Validation, Supervision, Methodology, Investigation. Gabriela Franco: Writing – review & editing, Writing – original draft, Visualization, Validation, Supervision, Investigation. Paola A. Castellanos: Writing – review & editing, Writing – original draft, Visualization, Validation, Supervision, Investigation, Formal analysis. Víctor S. Rangel: Writing – review & editing, Writing – original draft, Visualization, Validation, Supervision, Methodology, Funding acquisition. Footnotes The authors report no conflict of interest. This work was supported by Hospital Universitario Mayor-Méderi. Author contributions: All authors contributed substantially to the conception and design of the report, literature review, data interpretation, and manuscript writing. Each author meets all four ICMJE authorship criteria, including approval of the final version and agreement to be accountable for all aspects of the work. Ethics approval: Ethical approval was obtained from the Human Research Ethics Committee of Hospital Universitario Mayor–Méderi (Approval No. CEISH – 2026023). Consent to participate: Written informed consent was obtained in accordance with the directives of the institutional medical ethics committee. References